Skip to main content
SpringerLink
Log in

Differences in Nicotine-Induced Dopamine Release and Nicotine Pharmacokinetics Between Lewis and Fischer 344 Rats

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Studies have shown a greater preference for the self-administration of drugs such as nicotine and cocaine in the Lewis rat strain than in the Fischer 344 strain. We examined some factors that could contribute to such a difference. The baseline level of extracellular dopamine in nucleus accumbens shell was about 3-times higher in Fischer rats than in Lewis rats (3.18 ± 0.26 vs. 1.09 ± 0.14 pg/sample). Nicotine (50-100 μg/kg)-induced release of dopamine, expressed in absolute terms, was similar in the two strains. Dopamine release expressed in relative terms (as percent of baseline), however, was significantly greater in Lewis rats than in Fischer rats at 30 min after the first nicotine injection. We suggest that the relative increase is of more influence than the absolute level for determining preference; a lower physiological extracellular dopamine level thus represent a risk factor for increased preference. Amphetamine-induced dopamine release expressed in relative terms was not greater in the Lewis strain. In the initial time period of the microdialysis experiments, a sharper peak in nicotine-induced accumbal dopamine release in Lewis and a less but more sustained release in Fischer rats was observed. This release pattern paralleled the faster clearance of nicotine from blood of Lewis compared to Fischer rats. In tissue slices the electrically induced dopamine release was highest in the nucleus accumbens and lowest in the ventral tegmentum. A significant effect of nicotine was lowering the electrically induced release of dopamine in frontal cortex slices from Fischer brain and increasing this dopamine release in the ventral tegmentum of Lewis brain slices indicating that the ventral tegmentum, an area controlling dopamine release in the accumbens, is more responsive to nicotine in the Lewis rat. Nicotine levels tended to be more sustained in Fischer rats in different brain regions, although the difference in nicotine levels between the strains was not significant at any time period. Several factors contribute to nicotine preference, including the endogenous dopamine level, and the sensitivity of ventral tegmentum neurons to nicotine-induced dopamine release. Strain differences in pharmacokinetics of nicotine may also play a role.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Horan, B., Smith, M., Gardner, E. L., Lepore, M., and Ashby, C. R., Jr. 1997. (–)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Synapse 26:93–94.

    Google Scholar 

  2. Kosten, T. A., Miserendino, M. J., Haile, C. N., DeCaprio, J. L., Jatlow, P. I., and Nestler, E. J. 1997. Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains. Brain Res. 778:418–429.

    Google Scholar 

  3. Suzuki, T., George, F. R., and Meisch, R. A. 1988. Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains. J. Pharmacol. Exp. Ther. 245:164–170.

    Google Scholar 

  4. Stohr, T., Schulte Wermeling, D., Weiner, I., and Feldon, J. 1998. Rat strain differences in open-field behavior and the locomotor stimulating and rewarding effects of amphetamine. Pharmacol. Biochem. Behav. 59:813–818.

    Google Scholar 

  5. Shoaib, M., Schindler, C. W., and Goldberg, S. R. 1997. Nicotine self-administration in rats: Strain and nicotine pre-exposure effects on acquisition. Psychopharmacol. 129:35–43.

    Google Scholar 

  6. Sziraki, I., Sershen, H., Benuck, M., Hashim, A., and Lajtha, A. 1998. Receptor systems participating in nicotine-specific effects. Neurochem. Int. 33:445–457.

    Google Scholar 

  7. Paxinos, G. and Watson, C. 1998. The rat brain in stereotaxic coordinates. 4th Edition, Academic Press, N.Y.

    Google Scholar 

  8. Heffner, T. G., Hartman, J. A., and Seiden, L. S. 1980. Feeding increases dopamine metabolism in the rat brain. Science 208:1168–1170.

    Google Scholar 

  9. Davis, R. A. 1986. The determination of nicotine and cotinine in plasma. J. Chromatogr. Sci. 24:134–141.

    Google Scholar 

  10. Sziraki, I., Sershen, H., Benuck, M., Lipovac, M., Hashim, A., Cooper, T. B., Allen, D., and Lajtha, A. 1999. The effect of cotinine on nicotine-and cocaine-induced dopamine release in the nucleus accumbens. Neurochem. Res. 24:1471–1478.

    Google Scholar 

  11. Baumann, M. H., Elmer, G. I., Goldberg, S. R., and Ambrosio, E. 2000. Differential neuroendocrine responsiveness to morphine in Lewis, Fischer 344, and ACI inbred rats. Brain Res. 858:320–326.

    Google Scholar 

  12. Mocsary, Z. and Bradberry, C. W. 1996. Effect of ethanol on extracellular dopamine in nucleus accumbens: Comparison between Lewis and Fischer 344 rat strains. Brain Res. 706:194–198.

    Google Scholar 

  13. Flores, G., Wood, G. K., Barbeau, D., Quirion, R., and Srivastava, L. K. 1998. Lewis and Fischer rats: A comparison of dopamine transporter and receptors levels. Brain Res. 814:34–40.

    Google Scholar 

  14. Lindley, S. E., Bengoechea, T. G., Wong, D. L., and Schatzberg, A. 1999. Strain differences in mesotelencephalic dopaminergic neuronal regulation between Fischer 344 and Lewis rats. Brain Res. 832:52–158.

    Google Scholar 

  15. Strecker, R. E., Eberle, W. F., and Ashby, C. R., Jr. 1995. Extracellular dopamine and its metabolites in the nucleus accumbens of Fischer and Lewis rats: Basal levels and cocaineinduced changes. Life Sci. 56:135–141.

    Google Scholar 

  16. Minabe, Y., Emori, K., and Ashby, C. R., Jr. 1995. Significant differences in the activity of midbrain dopamine neurons between male Fischer 344 (F344) and Lewis rats: An in vivo electrophysiological study. Life Sci. 56:261–267.

    Google Scholar 

  17. Harris, H. W. and Nestler, E. J. 1996. Immunohistochemical studies of mesolimbic dopaminergic neurons in Fischer 344 and Lewis rats. Brain Res. 706:1–12.

    Google Scholar 

  18. Beitner-Johnson, D., Guitart, X., and Nestler, E. J. 1993. Glial fibrillary acidic protein and the mesolimbic dopamine system: Regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J. Neurochem. 61:1766–1773.

    Google Scholar 

  19. Guitart, X., Kogan, J. H., Berhow, M., Terwilliger, R. Z., Aghajanian, G. K., and Nestler, E. J. 1993. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: Studies in the nucleus accumbens and locus coeruleus of drug naïve and morphine-treated animals. Brain Res. 611:7–17.

    Google Scholar 

  20. Guitart, X., Beitner-Johnson, D., Marby, D. W., Kosten, T. A., and Nestler, E. J. 1992. Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mesolimbic dopamine system. Synapse 12:242–253.

    Google Scholar 

  21. Camp, D. M., Browman, K. E., and Robinson, T. E. 1994. The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats. Brain Res. 180–193.

  22. Deroche, V., Caine, S. B., Heyser, C. J., Polis, I., Koob, G. F., and Gold, L. H. 1997. Differences in the liability to self-administer intravenous cocaine between C57BL/6 × SJL and BALB/cByJ mice. Pharmacol. Biochem. Behav. 57:429–440.

    Google Scholar 

  23. Belzung, C. and Barreau, S. 2000. Differences in drug-induced place conditioning between BALB/c and C57B1/6 mice. Pharmacol. Biochem. Behav. 65:419–423.

    Google Scholar 

  24. Kuzmin, A. and Johansson, B. 2000. Reinforcing and neurochemical effects of cocaine. Differences among C57, DBA, and 129 mice. Pharmacol. Biochem. Behav. 65:399–406.

    Google Scholar 

  25. Collins, A. C. and Marks, M. J. 1991. Progress towards the development of animal models of smoking-related behaviors. J. Addict. Dis. 10:109–126.

    Google Scholar 

  26. Collins, A. C., Evans, C. B., Miner, L. L., and Marks, M. J. 1986. Mecamylamine blockade of nicotine responses: Evidence for two brain nicotinic receptors. Pharmacol. Biochem. Behav. 24:1767–1773.

    Google Scholar 

  27. Stolerman, I. P., Naylor, C., Elmer, G. I., and Goldberg, S. R. 1999. Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacol. 141:297–306.

    Google Scholar 

  28. Zhu, P. J. and Chiappinelli, V. A. 1999. Nicotine modulates evoked GABAergic transmission in the brain. J. Neurophysiol. 82:3041–3045.

    Google Scholar 

  29. Lecca, D., Shim, I., Costa, E., and Javaid, J. I. 2000. Striatal application of nicotine, but not of lobeline, attenuates dopamine release in freely moving rats. Neuropharmacol. 39:88–98.

    Google Scholar 

  30. Lucas, G. and Spampinato, U. 2000. Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. J. Neurochem. 74:693–701.

    Google Scholar 

  31. Meshul, C. K. and McGinty, J. F. 2000. Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons. Neurosci. 96:91–99.

    Google Scholar 

  32. Rahman, S. and McBride, W. J. 2000. Feedback control of mesolimbic somatodendritic dopamine release in rat brain. J. Neurochem. 74:684–692.

    Google Scholar 

  33. Epping-Jordan, M. P., Picciotto, M. R., Changeux, J. P., and Pich, E. M. 1999. Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacol. 147:25–26.

    Google Scholar 

  34. Le, A. D., Corrigall, W. A., Harding, J. W., Juzytsch, W., and Li, T. K. 2000. Involvement of nicotinic receptors in alcohol self-administration. Alcohol. Clin. Exp. Res. 24:155–163.

    Google Scholar 

  35. Reid, M. S., Mickalian, J. D., Delucchi, K. L., and Berger, S. P. 1999. A nicotine antagonist, mecamylamine, reduces cocaine craving in cocaine-dependent subjects, Neuropsychopharmacol. 20:297–307.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY

    I. Sziraki, A. Hashim, H. Sershen, D. Allen, T. Cooper & A. Lajtha

  2. Institute for Drug Research, Budapest, Hungary

    I. Sziraki

  3. Hunter College School of Health Sciences, New York, NY

    M. N. Lipovac

Authors
  1. I. Sziraki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. N. Lipovac
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Hashim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Sershen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Czobor
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Lajtha
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sziraki, I., Lipovac, M.N., Hashim, A. et al. Differences in Nicotine-Induced Dopamine Release and Nicotine Pharmacokinetics Between Lewis and Fischer 344 Rats. Neurochem Res 26, 609–617 (2001). https://doi.org/10.1023/A:1010979018217

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010979018217

Search

Navigation